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Synopsis
The transduction efﬁciency of Ad (adenovirus) depends, to some extent, on the expression level of CAR (coxsackievirus
and Ad receptor) of a target cell. The low level of CAR on the cell surface is a potential barrier to efﬁcient gene
transfer. To overcome this problem, PTD.AdeGFP (where eGFP is enhanced green ﬂuorescent protein) was constructed
by modifying the HI loop of Ad5 (Ad type 5) ﬁbre with the Tat (trans-activating) PTD (protein transduction domain)
derived from HIV. The present study showed that PTD.AdeGFP signiﬁcantly improved gene transfer to multiple cell
types deﬁcient in expression of CAR. The improvement in gene transfer was not the result of charge-directed binding
between the virus and the cell surface. Although PTD.AdeGFP formed aggregates, it infected target cells in a manner
different from AdeGFP aggregates precipitated by calcium phosphate. In addition, PTD.AdeGFP was able to transduce
target cells in a dynamin-independent pathway. The results provide some new clues as to how PTD.AdeGFP infects
target cells. This new vector would be valuable in gene-function analysis and for gene therapy in cancer.
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INTRODUCTION
Ad5 [Ad (adenovirus) type 5] has been shown to be able to trans-
duce multiple cell types, including lung epithelial cells [1,2],
muscle cells [3,4], endothelial cells [5,6], ﬁbroblasts [7,8] and
neuronal cells [9,10], with different transduction efﬁciencies as
a result of variable CAR (coxsackievirus and Ad receptor) ex-
pression levels on target cells. A low level of CAR on the cell
surface is a potential barrier to efﬁcient gene transfer [11–15].
Developmentofmoreefﬁcientvectorstoimprovegenetransferto
CAR-deﬁcientcells,forexample,tumorigeniccellsandneuronal
cells, will be critical for gene therapy of related diseases.
Ad5infectstargetcellsbyatwo-stepbindingprocess.Theﬁrst
step is the attachment of the virus to a ﬁbre receptor (i.e. CAR)
present on the cell surface, which determines the tropism of Ad5.
The second step is the interaction between the Ad penton base
RGD motif and the integrin αvβ5 on the target cell surface, lead-
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ingtoendocyticinternalizationoftheAd[16].Afewlaboratories
have attempted to ﬁnd approaches which improve transduction
of CAR-deﬁcient cells by Ad. They reported that Ad modiﬁed
by bi-functional antibodies could improve gene transfer to target
cells in vitro [17–19]. Experiments also showed that Ad capsids
genetically modiﬁed to contain a small foreign peptide at the C-
terminal or in the HI loop of the Ad5 ﬁbre allowed for efﬁcient
transduction of multiple cell types [20–24]. So far, as a result of
the structure of the Ad5 ﬁbre knob being solved, modiﬁcation
of the Ad5 ﬁbre is a common method used to alter the tropism of
Ad5 [25,26]. The tropism of genetically modiﬁed Ad, to some
extent, depends on the characteristics of the peptide inserted into
the HI loop of the ﬁbre.
The Tat (trans-activating) protein from HIV is composed of
86 amino acids encoded by two exons, and plays a critical role
in helping the replication of HIV inside infected cells. Interest-
ingly, a Tat protein-derived peptide sequence, also called a PTD
(protein transduction domain), has been used to help internalize
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a number of marker proteins into cells [27–30] by a transporter-
or receptor-independent mechanism. In the present study, by ge-
netically modifying the HI loop of Ad with Tat PTD, we proved
that Tat PTD could improve gene transfer to CAR-deﬁcient cells
by Ad. The present study also provided clues to the possible
mechanisms involved.
MATERIALS AND METHODS
Cells and viruses
All cells, except for the HUVECs (human umbilical-vein en-
dothelial cells) and C39 cells (a human ﬁbroblast cell line) were
from the A.T.C.C. HUVECs and the C39 cell line were supplied
by Dr Beverly L. Davidson (Department of Internal Medicine,
UniversityofIowa,IA,U.S.A.).ACHO(Chinese-hamsterovary)
cell line which stably expressed CAR (CHO–CAR) was gener-
ated in our laboratory. The AdeGFP virus contained an eGFP
[enhanced GFP (green ﬂuorescent protein)] gene in the E1 re-
gionunderthecontrolofanRSV(Roussarcomavirus)promoter.
E1-deleted Ad5 or AdeGFP was ampliﬁed in HEK-293 (human
embryonickidney)packagingcellsandpuriﬁedasdescribedpre-
viously by Xia et al. [21].
Virus construction
Tat PTD peptide (YGRKKRRQRRR) was inserted into the HI
loop of the Ad5 ﬁbre knob by overlapping PCR as described
previously by Xia et al. [21]. PCR was performed using two
pairs of primers: F1 (5 -AGAAATGGAGATCTTACTGAAGG-
C-3 )a n dR 1( 5  -GCCTCTTCGTCGCGTCTCCGCTTCTTCC-
TGCCATAGCCAGTTGTGTCTCCTGTTTCCTGTGTACC-3 )
and F2 (5 -GGCTATGGCAGGAAGAAGCGGAGACAGCGA-
CGAAGAGGCCCAAGTGCATACTCTATGTCATTTTCA-3 )
a n dR 2( 5  -AACACTAGTCTATTCTTGGGCAATGTATGA-
AAAAGTGTA-3 ), which were used to amplify a 210 bp and a
100 bp fragment of the Ad5 ﬁbre using puriﬁed virus genomic
DNA as a template. The reaction products were gel puriﬁed and
mixed, and contiguous sequences were generated by overlapping
PCR using primers F1 and R2. The PCR ampliﬁcation product
contained a unique BglII site at the 5 end and a SpeI site at
the 3  end. The digested fragment was cloned into BglII- and
SpeI-digested pTM1Ad5 ﬁbre. The resultant plasmid, named
pTM1/Ad5 Tat PTD-HI, was digested by SphI and SpeI and the
small fragment was puriﬁed and cloned into a pBS shuttle vector
[21]. The resultant plasmid was named pBS/Ad5 Tat PTD-HI.
The large fragments from pBS/Tat PTD-HI digested with EcoR1
and BamHI were co-transformed into Escherichia coli BJ5183
cells along with the SwaI-linearized pTG3602 RSVeGFP/SwaI
vector, and the positive clones were screened by enzyme
digestion and DNA sequencing. The resulting plasmid was des-
ignated PTD.AdeGFP. The PTD.AdeGFP virus was produced by
transfecting PacI-digested PTD.AdeGFP vector into HEK-293
cells. The virus was propagated in HEK-293 cells and puri-
ﬁed by caesium chloride gradient methods. The titres were
detected by spectrophotometry at an absorbance (A) of 260 nm.
Ad transduction
InexperimentstodetectgenedeliverytoCAR-positiveandCAR-
deﬁcient cells [31–33] by PTD.AdeGFP, CAR-positive A549
cells and CAR-deﬁcient cells indicated in the Figure legends
[105 cells in 1 ml of DMEM (Dulbecco’s modiﬁed Eagle’s
medium) containing 2% (v/v) FBS (fetal bovine serum) in a
60-mm-diameter dish] were incubated with PTD.AdeGFP or
unmodiﬁed AdeGFP (5000 particles/cell) at 37◦C for 1 h. The
cells were washed and incubated at 37◦C for 48 h. GFP expres-
sion was evaluated by FACS analysis. In experiments to test
the effect of the soluble Ad5 ﬁbre knob on PTD.AdeGFP in-
fection, 105 CAR-positive A549 cells or CAR-deﬁcient cells
were pre-incubated with 5 μg/ml soluble Ad5 ﬁbre knob for
1h a t 4 ◦C. The cells were washed and then incubated with
PTD.AdeGFP(5000 particles/cell)at37◦Cfor1 h.Thecellswere
washed and incubated at 37◦C for 48 h. A549 cells were infec-
ted by unmodiﬁed AdeGFP (5000 particles/cell) as a positive
control in the Ad5 ﬁbre-blocking assay experiments. Repres-
entative areas were then photographed by microscopy at ×20
magniﬁcation, except for C39 cells and HUVECs (×10 magni-
ﬁcation). To compare gene transduction of calcium phosphate
precipitated AdeGFP and PTD.AdeGFP, calcium phosphate pre-
cipitated AdeGFP and PTD.AdeGFP (8000 particles/cell) were
incubated with NIH 3T3 cells at 4◦C for 1 h, then the cells
were washed in 2% (v/v) DMEM medium or treated by tryp-
sin for 3–5 min at room temperature (25◦C). The trypsin-treated
cells were re-plated in 60-mm-diameter plates and incubated at
37◦C for 48 h. Representative areas were photographed using a
microscope at ×20 magniﬁcation. The cells were then detached
by trypsinization for FACS analysis. In experiments to determine
the effect of heparinase 1 (Sigma) on PTD.AdeGFP infection,
enzyme digestion was performed in 150 mM Tris/HCl (pH 7.5)
at 25◦C for 1 h in the presence of different concentrations of
heparinase 1. The indicated cells were then washed and incub-
ated with PTD.AdeGFP (5000 particles/cell) at 37◦C for 48 h.
The GFP expression was assayed by FACS analysis. In exper-
iments to test the effect of mutant dynamin on PTD.AdeGFP
infection, 5×104 A549 cells were infected with mutant dynamin
Ad or E1-deleted Ad5 (5000 particles/cell) and, after 48 h, the
cells were washed and incubated with PTD.AdeGFP or AdeGFP
(5000 particles/cell) at 37◦C for 1 h. The cells were washed and
incubatedat37◦Cforafurther48 h.GFPexpressionwasanalysed
by FACS. In experiments to determine the effect of the Tat PTD
peptide on PTD.AdeGFP infection, 5×104 CHO cells were pre-
incubatedat4◦Cfor1 hinthepresenceorabsenceoftheTatPTD
peptide (Genosys Biotechnologies) (2 μg/ml). The cells were
washed and incubated with PTD.AdeGFP (5000 particles/cell) at
37◦C for 1 h. The cells were washed again and incubated at 37◦C
for a further 48 h. GFP expression was analysed by FACS. In
experiments to determine gene transduction of CHO–CAR cells
by PTD.AdeGFP, 105 CHO–CAR or CHO cells were incubated
with PTD.AdeGFP (5000 particles/cell) at 37◦C for 1 h, then the
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Figure 1 Schematic diagram of PTD.AdeGFP production
PTD.AdeGFP contains the eGFP gene in the E1 region under the con-
trol of the RSV promoter. The pBS shuttle vector containing the Tat
PTD motif in the HI loop of Ad5 ﬁbre linearized by BamHI and EcoRI
was co-transformed into E. coli. BJ5183 cells along with SwaI lin-
earized pTG360RSVeGFP/SwaI. The positive clones were screened
by enzyme digestion and DNA sequencing. Appropriate recombi-
nants were digested by PacI and transfected into HEK-293 cells. Viruses
were harvested, ampliﬁed and puriﬁed using standard methods. Gluc,
glucuronidase.
cells were washed and incubated at 37◦C for 48 h. GFP expres-
sion levels were evaluated by FACS.
RESULTS
Efﬁcient gene transfer into CAR-deﬁcient cells is
mediated by PTD.AdeGFP
Using a homologous strategy in E. coli BJ5185 cells, Ad5 was
modiﬁed with the Tat PTD in the HI loop of the ﬁbre to obtain a
new construct, PTD.AdeGFP. The PTD.AdeGFP virus was then
producedbytransfectingPacI-linearizedPTD.AdeGFPplasmids
into HEK-293 cells (Figure 1). PTD.AdeGFP was ﬁrst tested in
A549 (a human lung epithelial cancer cell line), a CAR-positive
cell line. The results indicated that PTD.AdeGFP infected
A549 cells less efﬁciently when compared with the unmodi-
ﬁed control virus AdeGFP (Figure 2A). Flow cytometry showed
that 53% of A549 cells were infected by PTD.AdeGFP (re-
vealed by GFP expression) and 91% of the cells were infected
by AdeGFP. However, in contrast with the control virus Ade-
GFP, PTD.AdeGFP infected A549 cells in a fashion that was not
blockedbythepresenceofthesolubleﬁbreknob(Figure2A).We
next tested if PTD.AdeGFP could transduce CAR-deﬁcient cells
by using CHO cells, and the results revealed that 31% of the
cellswereinfected,whichwasnotreversedbypre-treatmentwith
the soluble Ad5 ﬁbre knob (results not shown). In addition, there
werenosigniﬁcantdifferencesintransductionefﬁciencybetween
CHO and CHO–CAR cells infected by PTD.AdeGFP (P>0.05)
(Figure2B).TheseresultssuggestedthatPTD.AdeGFPtranduces
cells in a CAR-independent manner. Other CAR-deﬁcient cells,
for example, NIH 3T3 (mouse ﬁbroblast cell line), C39 (human
ﬁbroblast cell line), T24 (human prostate cancer cell line) and
HUVECs all showed efﬁcient transduction (30%–50% GFP ex-
pression in cells) by PTD.AdeGFP (Figures 2C and 2D). To test
whether the enhanced gene transfer mediated by PTD.AdeGFP
in CAR-deﬁcient cells is the result of the insertion of the Tat
PTD into the HI loop of the adenoviral vector, PTD.AdeGFP
was incubated with CHO cells in the presence or absence of the
Tat PTD peptide. The results indicated that the Tat PTD peptide
could block the infection of CHO cells by PTD.AdeGFP by 50%
(Figure2E),suggestingthattheentryofPTD.AdeGFPintotarget
cells could be the result of an interaction between the Tat PTD
and molecules present on the surface of target cells.
Comparison of gene transduction by PTD.AdeGFP
and calcium phosphate precipitated AdeGFP
Interestingly, PTD.AdeGFP was found to form aggregates when
observed by electron microscopy (results not shown). Normally
Ad particles will not aggregate unless they are exposed to some
speciﬁc physical condition, for example, low pH or low ionic
strength [34]. Fasbender et al. [35] found that adenoviral ag-
gregates precipitated by calcium phosphate could enhance gene
transferintoairwayepitheliadeﬁcientinCARexpression.Totest
whetherhigh-efﬁciencygenetransferintoCAR-deﬁcientcellsby
PTD.AdeGFP is the result of aggregate formation, we incubated
NIH 3T3 cells at 4◦C for 1 h with PTD.AdeGFP and calcium
phosphate precipitated AdeGFP. The results showed that cal-
cium phosphate precipitated AdeGFP markedly enhanced gene
transfer (Figure 3A) and this effect was markedly blocked by
treatmentwithtrypsin(P<0.01)(Figure3).Notably,trypsinhad
no signiﬁcant effect on gene delivery mediated by PTD.AdeGFP
(P>0.05) (Figure 3). Precipitation of PTD.AdeGFP by calcium
phosphate was also performed and showed no effects on gene
transfertoNIH3T3cellscomparedwithuntreatedPTD.AdeGFP
(results not shown). These results suggested that PTD.AdeGFP
infects target cells in a different manner compared with calcium
phosphate precipitated AdeGFP.
The effect of heparinase 1 and mutant dynamin on
gene delivery by PTD.AdeGFP
Most mammalian cell types express heparin-containing cellular
receptorsthatcouldbindtochargedaminoacids[36,37].Previous
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Figure 2 Comparison of gene transduction by PTD.AdeGFP and control virus AdeGFP
(A) PTD.AdeGFP-infected A549 cells compared with unmodiﬁed control virus AdeGFP in the presence of soluble ﬁbre knob
(with soluble ﬁber knob) (5 μg/ml) or absence of soluble ﬁbre knob (w/o soluble ﬁber knob). (B) Comparison of gene
transduction by PTD.AdeGFP and AdeGFP in CHO–CAR or CHO cells. (C) Comparison of gene transduction by PTD.AdeGFP
and AdeGFP in different cell lines. Representative areas were imaged at ×20 magniﬁcation, except for C39 and HUVEC
cells (×10 magniﬁcation) using an Olympus IX70 microscope. (D) Comparison of gene transduction by PTD.AdeGFP and
AdeGFP in CAR-deﬁcient cells derived from different tissues. (E) Effect of the presence or absence of the Tat PTD peptide
on PTD.AdeGFP transduction in CHO cells. In (A, B, D and E), results are means+ −S.D. (n=3). Statistical signiﬁcance was
determined by the Student’s t test. 3T3, NIH 3T3.
studies indicated that adenoviral capsids modiﬁed to contain a C-
terminal poly-lysine tract allowed for an efﬁcient transduction of
multiple cell types via facilitated binding to cell surface heparan
sulfate proteoglycans [20]. The Tat PTD is enriched in positively
charged amino acids (YGKKKRRQRRR), and, in order to rule
out the possibility that the improvement of gene transfer is a
result of increased charge-directed binding between viruses and
cell surface, the cells were treated with heparinase 1 for 1 h at
25◦C prior to incubation with PTD.AdeGFP. The results indic-
ated that heparinase 1 had no effect on the infection of HUVECs
or T24 cells by PTD.AdeGFP (Figure 4A). After attaching
to the ﬁbre receptor on the cell surface, Ad5 is internalized
through the clathrin-coated-pit pathway, and dynamin is required
for the pathway [16]. To explore whether PTD.AdeGFP entered
intothecellsviatheclathrin-coated-pitpathway,A549cellswere
treated by Ad expressing mutant dynamin or E1-deleted Ad prior
to incubation with AdeGFP (control virus) or PTD.AdeGFP. The
results demonstrated that mutant dynamin inhibited transduction
by control viruses signiﬁcantly (P<0.01), but had no effects
on transduction by PTD.AdeGFP (Figure 4B), indicating that
PTD.AdeGFP infected the cells by a dynamin-independent
pathway.
DISCUSSION
The present study demonstrates that the Tat PTD-modiﬁed Ad
can effectively transduce CAR-deﬁcient cells. The infection of
target cells by PTD.AdeGFP is not via a pathway that Ad5 usu-
allyutilizes,i.e.viaclathrin-mediatedendocytosis.Theincreased
gene delivery to CAR-deﬁcient cells by PTD.AdeGFP is not the
result of the positivecharges thatthe Tat PTDcontains. Although
PTD.AdeGFP forms aggregates, it infects target cells in a differ-
ent manner compared with AdeGFP aggregates precipitated by
calcium phosphate.
AtrulytargetedAdisonewhichisdevoidofthenative-binding
ability of CAR [38] that is difﬁcult to construct and to propag-
ate in regular HEK-293 cells. As a result of the insight into the
structure of the Ad5 ﬁbre knob [25,26], an alternative approach
used is to incorporate a small foreign peptide into the HI loop of
the wild-type Ad5 ﬁbre to test its new tropism. Recently, Kurachi
et al. [39] generated Ad5 vectors containing a slightly different
Tat peptide (GRKKRRQRRRPQ) compared with the one used in
the present study, and the peptide was inserted into the HI loop
or the C-terminus of the ﬁbre knob. The modiﬁed virus
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Figure 3 Comparison of gene transduction by PTD.AdeGFP and
control virus precipitated by calcium phosphate
(A) NIH 3T3 cells were incubated with PTD.AdeGFP , Ad.eGFP:CaPi (cal-
cium phosphate precipitated AdeGFP) and AdeGFP at 4◦C for 1 h. The
cells were washed by 2% (v/v) DMEM medium or treated with tryp-
sin. The cells were incubated for a further 48 h at 37◦C and the cells
were analysed by FACS. Results are means+ −S.D. (n=4) and statistical
signiﬁcance was determined by the Student’s t test. (B) Cells treated
as in (A) were imaged at ×20 magniﬁcation using an Olympus IX70
microscope.
transduced efﬁciently into both the CAR-negative or -positive
cells [39]. However, the Ad5 virus produced in the present study
by inserting the Tat PTD sequence (YGKKKRRQRRR) into the
HIloopshowedadecreaseinthetransductionefﬁciencyofCAR-
positive cells. The discrepancy in these results might be associ-
ated with the differences in the sequences and insertion sites
of the Tat peptides between the two methods used. In addition,
the results from the present study also imply that conforma-
tional changes resulting from foreign peptide insertion into the
HI loop of the ﬁbre might impair the CAR-binding ability of
PTD.AdeGFP.
Another interesting phenomenon is the formation of viral ag-
gregates of PTD.AdeGFP. The enrichment of positively charged
Figure 4 The effect of PTD.AdeGFP infection on cells by hepar-
inase 1 or mutant dynamin
(A) The effect of heparinase 1 on infection of T24 or HUVEC cells by
PTD.AdeGFP . GFP-positive cells was detected as described in the Materi-
als and methods section. (B) The effect of mutant dynamin on infection
of A549 cells by PTD.AdeGFP or AdeGFP . A549 cells were pre-treated
with mutant dynamin virus (5000 particles/cell) or E1-deleted Ad5
(empty vector, 5000 particles/cell). After 48 h, cells were infected with
PTD.AdeGFP or AdeGFP and then washed and incubated at 37◦Cf o r
a further 48 h, after which the GFP-positive cells were detected as de-
scribed in the Materials and methods section. Results are means+ −S.D.
(n=3). Statistical signiﬁcance was determined using the Student’s t
test.
amino acids in the Tat PTD (YGKKKRRQRRR) is probably not
the sole cause of aggregate formation. The Ad5 constructed by
our laboratory previously did not form aggregates when the HI
loop of the Ad5 ﬁbre was inserted with a positively charged pep-
tide [21]. It was reported that adenoviral aggregates precipitated
by calcium phosphate enhanced gene transfer to airway epithelia
deﬁcient in CAR expression [35]. However, by using trypsin di-
gestion, the present study showed that PTD.AdeGFP infected
CAR-deﬁcient cells in a manner which was different from the
one used by calcium phosphate precipitated AdeGFP.
Most mammalian cell types express heparin-containing cel-
lular receptors that could bind to charged amino acids [36,37].
Adenoviral capsids modiﬁed to contain a C-terminal poly-lysine
tract allow for efﬁcient transduction of multiple cell types via
facilitated binding to cell-surface heparan sulfate proteoglycans
[20]. As mentioned above, the Tat PTD is enriched in positively
chargedaminoacids.But,asindicatedbytheresultsofthepresent
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study, heparinase 1 digestion did not reverse the improved gene
transfer of target cells by PTD.AdeGFP, which implies that the
increased transduction is not caused by charge-directed binding
betweenvirusesandthecellsurface.Thisresultisconsistentwith
the recent study by Kurachi et al. [39]. Our results also demon-
strate that the Tat PTD peptide could block infection of CHO
cells by PTD.AdeGFP, suggesting that the interaction of Tat PTD
withthemoleculespresentontargetcellsmediatesPTD.AdeGFP
entry into cells. After attaching to the ﬁbre receptor on the cell
surface, Ad5 is internalized through the clathrin-coated-pit path-
way [16]. Dynamin, a 100 kDa GTPase, is involved in this
pathway [16]. Overexpressed mutant dynamin did not lower the
gene transfer efﬁciency mediated by PTD.AdeGFP, suggesting
that PTD.AdeGFP infects the cells in a dynamin-independent
pathway. We propose that the interaction between the Tat PTD
and certain molecules on cell membranes may be involved in the
mechanism of PTD.AdeGFP entry into the target cells, which
needs to be elucidated further.
In conclusion, Tat PTD-modiﬁed Ad could effectively trans-
duce CAR-deﬁcient cells. The improvement of gene transfer is
not the result of charge-directed binding between the virus and
the cell surface. The entry into target cells of PTD.AdeGFP is
via a dynamin-independent pathway. Although PTD.AdeGFP
formsaggregates,itinfectstargetcellsinadifferentmannerfrom
AdeGFP aggregates precipitated by calcium phosphate. The new
constructwouldbeveryusefulingenefunctionanalysisandgene
therapy.
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